Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2021-03, Vol.11 (3), p.62-62, Article 62
Hauptverfasser:	Vazquez, Romain, Breal, Claire, Zalmai, Loria, Friedrich, Chloe, Almire, Carole, Contejean, Adrien, Barreau, Sylvain, Grignano, Eric, Willems, Lise, Deau-Fischer, Benedicte, Franchi, Patricia, Vignon, Marguerite, Decroocq, Justine, Birsen, Rudy, Goldwirt, Lauriane, Kaltenbach, Sophie, Couronne, Lucile, Fontenay, Michaela, Kosmider, Olivier, Bouscary, Didier, Chapuis, Nicolas
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 45 45/23 631/532/71 631/67/1990/283/1897 Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomedical and Life Sciences Biomedicine Bridged Bicyclo Compounds, Heterocyclic - adverse effects Bridged Bicyclo Compounds, Heterocyclic - therapeutic use Cancer Research Clonal Hematopoiesis - drug effects Correspondence Hematology Humans Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - pathology Neoplastic Stem Cells - drug effects Neoplastic Stem Cells - pathology Oncology Remission Induction Sulfonamides - adverse effects Sulfonamides - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!